Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis - Wikidata - wikimedia - TriplyDB

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis

http://www.wikidata.org/entity/Q34853017

about

Hypoxia-inducible factors as molecular targets for liver diseases Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1α Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis A novel antioxidant multitarget iron chelator M30 protects hepatocytes against ethanol-induced injury Effects of adenosine on lymphangiogenesis Caffeine inhibits the activation of hepatic stellate cells induced by acetaldehyde via adenosine A2A receptor mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK signal pathway Purinergic signaling in scarring.Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in Mice The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis.Purinergic signalling in the liver in health and disease.The significance of YKL-40 protein in liver fibrosis.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.Purinergic Signalling: Therapeutic Developments.How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.Disruption of Adenosine 2A Receptor Exacerbates NAFLD through Increasing Inflammatory Responses and SREBP1c Activity.Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.Alcoholic Hepatitis: Lost in Translation.

P2860

Q26752304-F57CB736-B764-4588-AFE4-4943E9C5EDBF Q33569405-A6C7DE55-0A5E-4C68-B2C4-60424BE686EA Q33971462-99A46B68-313F-4CA9-AED1-FBD8AE731523 Q34017968-04C38B69-9D46-4829-9187-5F769692CDC6 Q34373736-4850C64B-4310-4272-916B-F4BC94E0C583 Q34985968-72E7DD4C-E79E-41DA-AE7C-993B093CAB92 Q35102850-90D5E5F2-3DEB-477A-A9DE-D6DA5BBFB7E9 Q35126710-7D726973-BA1C-4E24-BEBB-76844E99B69D Q35135195-F27BD72B-2DB9-490F-92EB-D3F9EE5C18BC Q36385326-B35C5A34-F3FF-4B86-B44A-939E7B975AAC Q36731858-6601AFF9-D07B-4170-BAEF-75191C41500D Q36922236-78E84A23-D97D-4F69-8F92-F600F549E3E1 Q38165746-D97CBF7D-8809-4D14-9105-42461F48743A Q38179983-256229AD-6777-4B98-991B-5C887F13A06E Q39376604-5AD58579-B4EF-490F-98F9-4C149F928B43 Q42367885-C9A91979-A437-43F3-AF0B-E5FDD3C27025 Q42747703-823C5FC3-CB32-48F6-882F-9034B01A944B Q46282086-A67B4923-43C9-4961-90FA-49356A09FFFD Q47217999-3C4B7023-C88E-44C1-87AD-B7BEE3DC4610 Q48264506-3BDF73AB-8C26-44F7-B30A-2899EFF61435 Q50197688-75ED3E72-48ED-4901-A4E3-22CEF4881374 Q55396741-6CB4FCE5-81F2-4FA5-9EBC-B73B0BDC9B38

P2860

Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis

http://www.wikidata.org/entity/Q34853017

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@ast

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@en

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@nl

type

label

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@ast

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@en

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@nl

prefLabel

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@ast

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@en

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@nl

P1433

Q34853017-31A54E5D-EADE-41BE-9948-8DBFE23920E3

P1476

Q34853017-493A1FE8-BE9D-448A-AAEE-FDF44FB823FF

P2093

Q34853017-02FF0AF3-8BAD-4646-97A3-AF8D256EEC20

Q34853017-4625F74A-63BE-472F-997A-1D67405C0083

Q34853017-550BC02B-FC7B-49D4-A272-87C23FE1C637

Q34853017-A8DDF7D5-AD89-4F46-8948-76FB14119913

Q34853017-D0541913-0361-46B9-8061-2B15022F45A3

Q34853017-E24436B9-83AF-4C45-AA96-C3ED9DDC608E

Q34853017-EEB01888-98FA-4240-BE71-A1EDAC3898CA

Q34853017-F9807E1E-3E30-4042-89BC-9C4A9483A8C3

P2860

Q34853017-0FF2419E-A648-4F97-BA36-C5D89EDB28C5

Q34853017-1B069D81-F673-4AE1-9BA9-899073CBDA2E

Q34853017-23044EDD-492E-46C4-8567-208A56D4EDC2

Q34853017-23B1BDB9-0E99-4B9B-823C-E944705951C3

Q34853017-25B9C6A9-04BE-4735-A05B-68AF4DEEAD15

Q34853017-2D8CDA83-49D2-48AB-9F00-D8FC64AAC7D9

Q34853017-3167B3F6-0EEC-4B87-82DA-CC33B467C883

Q34853017-35522265-38D5-4507-A452-11A8177C99F8

Q34853017-3668CE95-F5E3-4A22-BE99-7F3AA6F08101

Q34853017-369F2C88-8D13-467C-8EF8-EC34CC9B6644

P304

Q34853017-D462F73A-7F8C-4DDB-8BDB-6D0B9082C5D0

P31

Q34853017-CB1B5E40-2F66-4DD9-A64B-309981F125F2

P356

Q34853017-EFFCB953-7816-426E-9CA7-5A7F22074905

P407

Q34853017-331A6CAD-E889-4CC7-8DB5-13CEA7812922

P433

Q34853017-5E65A604-511B-4619-B202-D20375BEC6FA

P478

Q34853017-97CD1F1F-50BC-42A9-89D2-D765CC6340E7

P50

Q34853017-415D78E3-B868-453A-9197-9836C1FC9B61

P577

Q34853017-BFB88CB0-BC87-4430-BE98-A20AC2049A21

P5875

Q34853017-D0BB34FF-2FD5-472D-B58B-6785827EA25A

P698

Q34853017-015AE6BE-C1F8-4D1F-88D3-A86D0687F369

P932

Q34853017-6513EAF0-0155-48DC-8D2D-5FE9920400C4

P356

JOURNAL.PONE.0069114

P1433

P1476

Adenosine 2A receptor antagoni ...... nol-exacerbated liver fibrosis

@en

P2093

Dian J Chiang

http://www.w3.org/2001/XMLSchema#string

Katelyn Bush

http://www.w3.org/2001/XMLSchema#string

Kathryn Niese

http://www.w3.org/2001/XMLSchema#string

Laura E Nagy

http://www.w3.org/2001/XMLSchema#string

Megan R McMullen

http://www.w3.org/2001/XMLSchema#string

Mitchell A Olman

http://www.w3.org/2001/XMLSchema#string

Sanjoy Roychowdhury

http://www.w3.org/2001/XMLSchema#string

Sorana Pisano

http://www.w3.org/2001/XMLSchema#string

P2860

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.

ALCOHOL: its metabolism and interaction with nutrients.

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

Extracellular metabolism of ATP and other nucleotides.

Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease

Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.

Adenosine A2A receptor blockade or deletion diminishes fibrocyte accumulation in the skin in a murine model of scleroderma, bleomycin-induced fibrosis.

Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis

P304

e69114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0069114

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Michele T Pritchard

P577

2013-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

250926361

http://www.w3.org/2001/XMLSchema#string

P698

23874883

http://www.w3.org/2001/XMLSchema#string

P932

3715448

http://www.w3.org/2001/XMLSchema#string